Inhibition of the Spinal Phosphoinositide 3-Kinase Exacerbates Morphine Withdrawal Response.

Li Yang,Chang-Jiang Zhu,Jun-Li Cao,Yin-Ming Zeng
DOI: https://doi.org/10.1016/j.neulet.2006.05.056
IF: 3.197
2006-01-01
Neuroscience Letters
Abstract:The present study investigates the roles of the spinal phosphoinositide 3-kinase (PI3K) signaling pathway in naloxone-precipitated withdrawal in acute and chronic morphine-dependent mice. There are two principal findings: (1) intrathecal pretreatment with wortmannin or LY294002, two structurally unrelated PI3K inhibitors, produced a dose-dependent increase of naloxone-precipitated withdrawal jumping, which was accompanied by an increased expression of spinal Fos protein in acute and chronic morphine-dependent mice; and (2) the expression of spinal p110γ, the catalytic subunit PI3K, in the membrane fraction was significantly down-regulated by naloxone-precipitated withdrawal in acute and chronic morphine-dependent mice. This study provides new evidence showing that inactivation of the PI3K signaling pathway in the spinal cord may be involved in the expression of morphine withdrawal.
What problem does this paper attempt to address?